Slovakia was the second in the EU to use Sputnik V after Hungary.
Due to a breach of contract, Slovakia will have to return the Sputnik V vaccine delivered to it, the Russian Direct Investment Fund (RFPI), which finances the development of Russian vaccines and manages its foreign production, told Twitter on Thursday.
Unfortunately, in violation of the current treaty, the Slovak State Institute for Pharmacovigilance (SIDC) committed sabotage, deliberately sending Sputnik V to a laboratory outside the EU pharmacovigilance network for testing, although such laboratories were available.
– stated in the RFPI communication.
The Slovak authority has previously complained that the vaccine from Russia does not match the samples tested by the European Medicines Agency (EMA) and studied by The Lancet. This statement was classified as a lie by the RFPI.
The SIDC has embarked on a disinformation campaign against Sputnik V and is preparing for further provocations. SIDC’s claim that the Sputnik V consignment sent to Slovakia does not have the same properties as the vaccine described by The Lancet is false news
The RFPI said in a report by Kommersant.
The Russian sovereign fund stressed that vaccine shipments are subject to strict quality control by the Gamaleja Institute, and their quality has been confirmed by regulators in 59 countries.
The RFPI asked the Slovak government to send the vaccine to an EU-certified laboratory for testing and sent a letter on 6 April asking for the vaccine to be returned due to repeated breaches of contract, so that it could still be used in other countries.
Slovakia, the second in the European Union to approve the use of Sputnik V after Hungary, received the first consignment of 200,000 doses of vaccine on 1 March, which had to be inspected by the Slovak authority before use. The treaty met with serious political resistance in Bratislava, leading to the resignation of Slovak Prime Minister Igor Matovic.
Cover image: MTI / Péter Komka